Bridging the Gap: How Cross-Industry Talent Is Powering Pharma’s Next Wave
- Nov 28, 2025
- 4 min read
The life sciences and pharmaceutical sectors are undergoing seismic change.
Breakthroughs in AI-driven drug discovery, digital therapeutics, and patient-centric care are pushing companies to hire beyond the traditional “PhD plus bench experience” mold. At the same time, organisations across sectors are realising that talent from adjacent industries often brings fresh thinking, user insights, and agility. This isn’t just theory; it is happening now, with high-profile leaders exemplifying the shift.One striking example is Emma Walmsley, currently stepping down as CEO of GSK, who built much of her career in consumer goods before pivoting into pharma. Her journey illustrates a powerful truth: cross-sector experience can translate into leadership in biopharma.This article explores why pharma is opening the door to non-traditional talent, which transferable skills make the difference, and what this signals for professional development in all sectors.
The Demand for Diverse Talent in Life Sciences
The life sciences industry is growing faster than many parallel sectors, creating fierce competition for talent.1 Yet many roles, particularly in digital health, medical affairs, regulatory strategy, and patient engagement, now require capabilities such as data literacy, user research, and systems thinking that exist outside traditional pharma pipelines. The World Economic Forum’s Future of Jobs Report 2025 highlights how employers are shifting toward hybrid skill sets over rigid job categories.2 Recent talent research highlights the importance of hiring for potential rather than direct industry experience, as organisations seek to overcome widening skills gaps by reimagining how they develop and deploy people.3 The old, siloed pathways will not scale. Pharma must tap into a broader talent pool, viewing adjacent experience as an asset rather than a liability.
The Walmsley Example: Consumer Roots, Pharma Heights
Emma Walmsley’s trajectory is a compelling case of cross-industry leadership.She spent 17 years at L’Oréal, holding marketing and general-management roles in Europe, North America, and China, before joining GSK in 2010.4 At GSK she began in consumer healthcare roles and eventually rose to CEO in 2017, becoming the first woman to lead a major pharmaceutical company.5 Observers credit her consumer experience with injecting a “customer-first” mindset into GSK’s approach to patient engagement, marketing, and operations. Her arrival helped reposition the consumer health division from a supportive unit into a strategic asset.6 Her background also enabled her to navigate complexity and change, bringing capabilities in brand strategy, cross-market insights, stakeholder alignment, and organisational transformation.6Walmsley’s path is not the norm, but increasingly it is a roadmap that others are following. Her success signals that pharma is ready to value how professionals think and what they have achieved, not only where they have worked.
Transferable Skills That Unlock Value Across Sectors
Transferable Skill | Why It Matters in Pharma and Life Sciences |
Strategic Thinking and Systems Understanding | Drug development and commercialisation challenges require navigating complex systems such as regulation, payers, and health systems. |
Customer and User Insight with Commercial Acumen | Patient journeys, market access, and digital health tools increasingly demand user experience and adoption expertise. |
Digital Literacy and Data Fluency | Analytics, AI, and real-world evidence require proficiency with data in most emerging pharma roles. |
Change Leadership and Agility | Pharma is in flux. Professionals who can drive transformation, manage uncertainty, and influence cross-functionally have outsized impact. |
Communication and Stakeholder Alignment | Bridging the gap among science, business, regulators, and patients demands advanced communication and translation skills. |
A recent study on skill-based hiring shows that across emerging tech sectors, employers are de-emphasising formal degree requirements and placing more weight on what people can do.7
What This Means for Professional Development and CPD
Frame learning around capability, not only credentials. CPD offerings that build hybrid skills such as data literacy, stakeholder strategy, and digital health are becoming more relevant and portable.
Encourage lateral experiences. Rotations, secondments, or cross-sector projects help professionals gain adjacent exposure before making a full pivot.
Design learning pathways with blending in mind. Courses that overlay pharma context on top of external skills minimise the gap when transitioning.
Advocate for hidden-potential metrics. Organisations should measure potential, learning agility, and adaptability rather than relying solely on past industry experience.
With cross-industry talent increasingly valued, CPD organisations have a unique opportunity to equip professionals with bridging skills that allow them to move fluidly between sectors.
Conclusion
Pharma’s future will not be built solely by those who have always worked within its walls. It will be shaped by people who bring fresh perspectives, cross-pollination, and boundary-spanning skills. Emma Walmsley stands as a powerful example of that shift, but she is only the beginning.For professionals in any field, the takeaway is clear: develop skills you can carry across contexts. Learn to speak the languages of data, systems, user insight, and change leadership, because tomorrow’s career pivots will increasingly depend on them.
References
1. Experis. Life Sciences Recruitment Trends. Available at: https://www.experis.com/en/insights/articles/life-sciences-recruitment-trends (accessed October 2025).
2. World Economic Forum. Future of Jobs Report 2025. Available at: https://reports.weforum.org/docs/WEF_Future_of_Jobs_Report_2025.pdf (accessed October 2025).
3. McKinsey & Company (2024) Reimagining People Development to Overcome Talent Challenges. Available at: https://www.mckinsey.com/capabilities/people-and-organizational-performance/our-insights/reimagining-people-development-to-overcome-talent-challenges (accessed October 2025).
4. The Guardian. Emma Walmsley Profile: From L’Oréal to GSK Chief. 2016. Available at: https://www.theguardian.com/business/2016/sep/20/emma-walmsley-profile-loreal-gsk-chief-designate-glaxosmithkline (accessed October 2025).
5. Wikipedia. Emma Walmsley. Available at: https://en.wikipedia.org/wiki/Emma_Walmsley (accessed October 2025).
6. European CEO. Prescription for Success: Emma Walmsley Leads GSK Transformation. Available at: https://www.europeanceo.com/profiles/prescription-for-success-emma-walmsley-leads-gsk-transformation (accessed October 2025).
7. Gonzalez Ehlinger, Eugenia and Stephany, Fabian, Skills or Degree? The Rise of Skill-Based Hiring for AI and Green Jobs (February 25, 2024). Available at SSRN: https://ssrn.com/abstract=4603764 or http://dx.doi.org/10.2139/ssrn.4603764
Comments